Cryptococcus neoformans promotes its transmigration into the central nervous system by inducing molecular and cellular changes in brain endothelial cells

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3139-3147

  Vu, Kiem ^a   Eigenheer, Richard A ^b   Phinney, Brett S ^b   Gelli, Angie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A; HIGH MOBILITY GROUP B1 PROTEIN; LIPOCORTIN 2; MYOSIN; TRANSGELIN;

ARTICLE; BRAIN CELL; CELL DAMAGE; CELL MEMBRANE; CELL STRESS; CENTRAL NERVOUS SYSTEM; CRYPTOCOCCUS NEOFORMANS; CYTOSKELETON; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENERGY YIELD; HUMAN; HUMAN CELL; INFLAMMATION; MASS SPECTROMETRY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; UPREGULATION;

EID: 84884214543     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00554-13     Document Type: Article

References (59)

1. Antinori S. 2013. New insights into HIV/AIDS-associated Cryptococcosis. ISRN AIDS 2013:2-22.
2. Mitchell TG, Perfect JR. 1995. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
3. Sorvillo F, Beall G, Turner PA, Beer VL, Kovacs AA, Kerndt PR. 1997. Incidence and factors associated with extrapulmonary cryptococosis among persons with HIV infection in Los Angeles County. AIDS 11:673-679.
4. Bicanic T, Harrison TS. 2004. Cryptococcal meningitis. Br. Med. Bull. 72:99-118.
5. Zuger A, Louie E, Holzman RS, SimberkoffMS, Rahal JJ. 1986. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann. Intern. Med. 104:234-240.
6. Casadevall A, Perfect JR. 1998. Cryptococcus neoformans. American Society for Microbiology, Washington, DC.
7. Ecevit IZ, Clancy CJ, Schmalfuss IM, Nhuyen MH. 2006. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin. Infect. Dis. 42:1443-1447.
8. Park BJ, Wannemeuhler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530.
9. Kidd SE, Hagen F, Tscharke RL, Huynh M, Barlett KH, Fyfe M, Macdougall L, Boekhout T, Kwon-Chung KJ, Meyer W. 2004. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl. Acad. Sci. U. S. A. 101:17258-17263.
10. Byrnes EJ, III, Li W, Lewit Y, Ma H, Voelz K, Ren P, Carter DA, Chaturvedi V, Bildfell RJ, May C, Heitman J. 2010. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the Northwest United States. PLoS Pathog. 6:1-11.
11. Chretien F, Lortholary O, Kansaue I, Neuville S, Gray F, Dromer F. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J. Infect. Dis. 186:522-530.
12. Abbott NJ, Ronnback L, Hansson E. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7:41-53.
13. Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, Dam T, Paul-Satyaseela M, Kim KS, Kwon-Chung KJ. 2004. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect. Immun. 72:4985-4995.
14. Vu K, Weksler B, Romero I, Couraud PO, Gelli A. 2009. An immortalized human brain endothelial cell line HCMEC/D3, as a model of the blood-brain barrier facilitates in vitro studies of CNS infection by Cryptococcus neoformans. Eukaryot. Cell 8:1803-1807.
15. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. 2009. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect. Immun. 77:120-127.
16. Chen SH, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, Chang Y, Kim KS. 2003. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J. Med. Microbiol. 52:961-970.
17. Jong A, Wu CH, Shackelford GM, Kwon-Chung KJ, Chang YC, Chen HM, Ouyang Y, Huang SH. 2008. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell. Microbiol. 10:1313-1326.
18. Tseng HK, Liu CP, Price MS, Jong AY, Chang JC, Toffaletti DL, Betancourt-Quiroz M, Frazzitta AE, Cho WL, Perfect JR. 2012. Identification of genes from the fungal pathogen Cryptococcus neoformans related to transmigration into the central nervous system. PLoS One 7:e45083. doi:10.1371/journal.pone.0045083.
19. Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, Huffnagle GB. 2004. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am. J. Pathol. 164:1761-1771.
20. Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F. 2005. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am. J. Pathol. 166:421-432.
21. Huang SH, Long M, Wu CH, Kwon-Chung KJ, Chang YC, Chi F, Lee S, Jong A.2011. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid raftsendocytic pathway via the dual specificity tyrosine phosphorylationregulated kinase 3 (DYRK3). J. Biol. Chem. 286:34761-34769.
22. Stie J, Fox D. 2012. Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiology 158:240-258.
23. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. 2002. Empirical statistical model to estimate the accuracy of peptides identifications made by MS/MS and database search. Anal. Chem. 74:5383-5392.
24. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75:4646-4658.
25. Choi H, Fermin D, Nesvizhskii AI. 2008. Significance analysis of spectral count data in label-free shotgun proteomics. Mol. Cell. Proteomics 712:2373-2385.
26. Bensmail H, Golek J, Moody MM, Semmes JO, Haoudi A. 2005. A novel approach for clustering proteomics data using Bayesian fast Fourier transformation. Bioinformatics 21:2210-2224.
27. Weksler BB, Subileau N, Perriere P, Charneau K, Holloway M, Leveque H, Tricoire-Leignel A, Nicotra S, Bourdoulous P, Turowski DK, Male F, Roux J, Greenwood IA, Romero I, Couraud PO. 2005. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19:1872-1874.
28. Dauchy S, Miller F, Couraud PO, Weaver RJ, Weksler B, Romero IA, Schermann JM, De Waziers I, Decleves X. 2009. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem. Pharm. 77:897-909.
29. Fasler-Kan E, Suenderhaul C, Barteneva N, Poler B, Gygax D, Huwyler J. 2010. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3. Brain Res. 1354:15-22.
30. Tai LM, Reddy S, Lopez-Ramirez MA, Davies HA, Male DK, Loughlin AJ, Romero IA. 2009. Polarized P-glycoprotein expression by the immortalized human brain endothelial cell line, hCMEC/D3, restricts apical-tobasolateral permeability to rhodamine 123. Brain Res. 1292:14-24.
31. Urich E, Lazic SE, Molnos J, Wells I, Freskard PO. 2012. Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models. PLoS One 7:e38149. doi:10.1371/journal.pone.0038149.
32. Katz E, Fon M, Eigenheer RA, Phinney BS, Fass JN, Lin D, Sadka A, Blumwald E. 2010. A label-free differential quantitative mass spectrometry method for the characterization and identification of protein changes during citrus fruit development. Proteome Sci. 8:68. doi:10.1186/1477-5956-8-68.
33. Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washbur MP. 2006. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J. Proteome Res. 5:2339-2347.
34. Sayeed S, Asano E, Ito S, Ohno K, Hamaguchi M, Senga T. 2013. S100A10 is required for the organization of actin stress fibers and promotion of cell spreading. Mol. Cell. Biochem. 374:105-111.
35. 2+ signaling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6:449-461.
36. Morel E, Gruenberg J. 2007. The p11/S100A10 light chain of Annexin A2 is dispensable for Annexin A2 association to endosomes and functions in endosomal transport. PLoS One 2:e1118. doi:10.1371/journal.pone.0001118.
37. Rescher U, Ludwig C, Konietzko V, Kharitonenkov A, Gerke V. 2008. Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion. J. Cell Sci. 121:2177-2185.
38. Hayes MJ, Shao D, Baily M, Moss SE. 2006. Regulation of actin dynamics by annexin 2. EMBO J. 25:1816-1826.
39. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195.
40. Lotze MT, Tracey KJ. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5:331-342.
41. Higgins SJ, Zing K, Dylan HK, Wang F, Dhabangi A, Musoke C, Cserti-Gazdewich CM, Tracey KJ, Kain KC, Liles WC. 2013. Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria. Malar. J. 12:105. doi:10.1186/1475-2875-12-105.
42. Chen Y, Chen J, Wen H, Gao P, Wang J, Zheng Z, Gu J. 2011. S100A10 downregulation inhibits the phagocytosis of Cryptococcus neoformans by murine brain microvascular endothelial cells. Microb. Pathog. 51:96-100.
43. Wang XJ, Zhu YJ, Cui JG, Huang X, Gu J, Xu H, Wen H. 2011. Proteomic analysis of human umbilical vein endothelial cells incubated with Cryptococcus neoformans var. neoformans. Mycoses 54:e336-e343.
44. Shi M, Li SS, Zheng C, Jones GJ, Kim KS, Zhou H, Kubes P, Mody CH. 2010. Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J. Clin. Invest. 120:1683-1693.
45. Schubert-Unkmeir A, Sokolova O, Panzner U, Eigenthaler M, Frosch M. 2007. Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis. Infect. Immun. 75:899-914.
46. Eugene E, Hoffmann I, Pujol C, Couraud PO, Bourdoulous S, Naffif X. 2002. Microvilli-like structures are associated with the internalization of virulent capsulated Neisseria meningitidis into vascular endothelial cells. J. Cell Sci. 115:1231-1241.
47. Redell JB, Zhao J, Dash PK. 2007. Acutely increased cyclophilin A expression after brain injury: a role in blood-brain barrier function and tissue preservation. J. Neurosci. Res. 85:1980-1988.
48. HaseloffRF, Krause E, Bigi M, Mikoteit K, Stanimirovic D, Blasi IE. 2006. Differential protein expression in brain capillary endothelial cells induced by hypoxia and posthypoxic reoxygenation. Proteomics 6:1803-1809.
49. Sherry B, Yarlett N, Strupp A, Cerami A. 1992. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharideactivated macrophages. Proc. Natl. Acad. Sci. U. S. A. 89:3511-3515.
50. Kim SH, Lessner SM, Sakurai Y, Galis ZS. 2004. Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction. Am. J. Pathol. 164:1567-1574.
51. Grammas P, Martinez J, Miller B. 2011. Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev. Mol. Med. 13:1-22.
52. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. 2010. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell. Biol. 11:700-714.
53. Teresa M, Leaver HM. 2010. Brain endothelial cell death: modes, signaling pathways and relevance to neural development, homeostasis and disease. Mol. Neurobiol. 42:52-63.
54. Xu C, Baily-Maitre B, Reed JC. 2005. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115:2656-2664.
55. Ibrahim AS, Filler SG, Alcouloumre MS, Kozel TR, Edwards JE, Jr, Ghannoum MA. 1995. Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect. Immun. 63:4368-4374.
56. Zong WX, Thompson CB. 2006. Necrotic death as cell fate. Genes Dev. 20:1-15.
57. Kaczmarek A, Vandenabeele P, Krysko DV. 2013. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 38:209-223.
58. Vanlangenakker N, Berghe TV, Vandenabeele P. 2012. Many stimuli pull the necrotic trigger, an overview. Cell Death Differ. 19:75-86.
59. Wu W, Liu P, Li J. 2012. Necroptosis: an emerging form of programmed cell death. Crit. Rev. Oncol. Hematol. 82:249-258.